Arcutis Biotherapeutics, Inc.
ARQT
株式のランク
#4365
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
株価
$28.54
最終同期: 2026-10-16
時価総額
$3.59B
変化（1日）
-1.94%
変化（1年）
36.66%
国
US
取引 Arcutis Biotherapeutics, Inc. (ARQT)
カテゴリー
Healthcare
Arcutis Biotherapeutics, Inc.（ARQT）の営業利益率
October 2026 時点の営業利益率 TTM: 7.38%
Arcutis Biotherapeutics, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 7.38% です。2023 年末時点では -404.49% でした。
Arcutis Biotherapeutics, Inc. の営業利益率の履歴（2017 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 7.38% | -111.30% |
| 2024 | -65.33% | -83.85% |
| 2023 | -404.49% | -95.06% |
| 2022 | -8,183.04% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | -94.77% |
US
|
|
| -149.01% | -120.19% |
US
|
|
| 25.57% | -96.54% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -96.10% |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。